Located in Wolverhampton, the new practice uses different lighting in different parts of the building: 'cool' for public areas such as the waiting room, 'comfortable warm' for the dog, cat and exotic wards and daylight for clinical areas. The LED system uses 60% less energy than conventional lighting and requires half the number of fittings. In addition, following research in the USA at Banfield, consulting rooms are fitted with dimmable lights to ease stress for patients and clients during euthanasia.
Other highlights include a specialist cat ward that White Cross says exceeds the iCatCare Cat Friendly Clinic requirements. The ward includes raised cat kennels that are carefully positioned so that cats can’t see each other, to further minimise stress-levels. There are also separate, sound-proofed wards for dogs and exotic pets.
To reduce anxiety in dogs and cats pre- and post-surgery, the practice uses pheromone diffusers and specially composed music played in the wards.
Managing Director, Tim Harrison said: "We’re delighted to launch our latest practice in Wolverhampton, which is our most environmentally-friendly yet. We’ve incorporated the most successful attributes from all of our 15 other UK practices into its design, and it’s immediately proving popular with clients and most importantly their pets."
Clinic Director James Millington says: "The facilities and attention to detail in this practice are the best I’ve ever seen. There’s no doubt this will translate into the quality of care that our clients receive and their pets deserve."
Fort Dodge, which supplies Bluetongue vaccine in continental Europe, has licensed its cattle vaccine in the UK and is now launching the product onto the UK market.
The company has already won and met tenders from several European governments, including France, Spain, Italy, Portugal Germany, Switzerland, Belgium and the Czech Republic for its Zulvac 8® Bovis vaccine and says it is the only international company to have produced vaccines for the most commonly occurring serotypes of the disease including 8, 4 and 1.
Approved by the VMD with a Provisional Marketing Authorisation, Zulvac 8 is available in 50 dose and 10 dose packs. The key claims are active immunisation against Bluetongue serotype 8 of cattle from 2.5 months old and a significant reduction of viraemia.
The vaccine is administered in 2 x 2 ml doses at three week intervals given by intra muscular injection and the product is supported by a fixed 2ml multidose applicator with Sterimatic needle protector and cleaning system to ensure accurate dosing and hygienic conditions.
John Hanley, Managing Director of Fort Dodge UK, said: "We were first to market with our Zulvac 8 product in three European countries and have received an Award for Agricultural Merit from the Spanish Government for our work in Bluetongue control. Following the licensing of Zulvac 8 Bovis in the UK we now have the opportunity to launch the product onto the UK market.
"In terms of pricing, Zulvac 8 is competitive per dose against other products in the market and it is supported by the experience gained in Europe with millions of animals already vaccinated. We're delighted that the VMD have authorised the vaccine and believe its availability can play a key role in protecting the UK's cattle from this dreadful disease."
The product is authorised for use by cattle farmers in the protection zone only, and will require veterinary prescription. Farmers can administer the vaccine to their cattle and the 2ml intra-muscular injection will be an advantage in aiding administration especially when used with Zulvac Bovis applicator with sterimatic needle protector and cleaning system.
The first batches will be available from veterinary wholesalers from week commencing 22nd September 2008.
A quick survey of VetSurgeon members1 has found that of those that didn't vote in the 2011 council elections, 37.9% 'did not believe that voting in the RCVS elections will have any impact on my working life'
However, as Wynne Richards pointed out, decisions made by the RCVS, or which have involved the RCVS have had a seismic impact on the profession over the years, things like:
... and so on, and so on.
So perhaps the issue is not whether or not the College is relevant to the working lives of its members. Clearly it is. More to the point, the College and its Councillors need to find ways to engage more with the profession and better demonstrate how the decisions it takes on the issues of the day will impact on its members.
This message is further hammered home by the 26% of voters who didn't vote because they: 'considered the candidates' manifestos / forum posts, but did not feel that any of the candidates deserved my vote'. Again, if the councillors had concentrated on explaining why their work would make a difference, perhaps that number could have been improved.
Of the remainder, 21% 'forgot', 8.7% 'didn't have the time to consider who to vote for, and vote', 4.9% gave other reasons. Again, all things which might be improved if members felt that the RCVS was relevant to their working lives.
1% 'weren't aware that the elections were taking place'.
One wonders if that 1% knows that Clement Attlee is no longer the Prime Minister.
1. VetSurgeon Poll 6th May - 8th August 2011. 103 respondents.
The Royal College of Veterinary Surgeons has refused to release the McKelvey Report in full, despite Freedom of Information requests made by VetSurgeon.org and others.
According to the College, it had always been the intention of RCVS Officers that the full report, which considered the building works in the Lower Ground Floor of the RCVS offices in Belgravia House, and the implementation of a new database, would be published.
However, on the advice of solicitors (Penningtons), only the recommendations of the Report were published initially, in November.
This publication followed discussion of the full report (one sentence was redacted on legal advice) by RCVS Council on 3 November.
Freedom of Information requests for the full report were then received by the College, so further, external senior legal advice was sought.
This advice, from Counsel, confirmed the original view from solicitors that it would be inappropriate to publish the report in full because it includes personal data, which ought not to be made public, under the Data Protection Act.
The College claims the meat of the report is in the recommendations, which account for approximately 50% of the report, and which are being taken forward by Officers and RCVS Council, with plans to put an Audit and Risk Committee in place taking priority.
The recommendations of the report, which were adopted by Council, were published online on 11 November and are available to download from the 'Related documents' box, above right.
A new study1 lead by led by Dr Séverine Tasker at the University of Bristol's School of Veterinary Sciences and published in the journal Clinical and Vaccine Immunology (CVI), has shown that cats previously infected with the blood-borne bacteria M. haemofelis develop immunity from re-infection.
Haemoplasmas are a group of blood borne bacteria found in a wide range of mammals, including domestic and wild cats, and can cause severe anaemia. The findings of the new study have significantly advanced researchers' knowledge of immunity for these pathogens.
Information about the immune responses that occur in animals following haemoplasma infection is relatively unknown, largely due to the fact that researchers struggle to study these bacteria as they are unable to grow them in the laboratory. Antibiotics do not consistently clear infection and without correct treatment the anaemia can be fatal. Recently haemoplasma associated anaemia has been reported in a human too.
The aim of the study was to determine whether cats who had previously recovered from M. haemofelis infection were protected from re-infection. The researchers found that they were, representing a significant advancement in scientists' knowledge of immunity for haemoplasma infections.
The exact methods of protective immunity could not be clearly identified despite extensive investigations, but the study's results suggest that a vaccine, using a weakened form of the bacteria, may offer protection against haemoplasma infection.
Séverine said: "This is the first study to demonstrate protective immunity against M. haemofelis reinfection and it provides important information for a possible future haemoplasma vaccine.
"Our findings could help prevent the disease in cats and could also be of particular importance to farm animal species where haemoplasma infections can cause huge financial losses."
The study recommends future research should explore whether the bacterial animal infection could be transmitted to humans and how the immune system targets the pathogen.
Reference
The RCVS Disciplinary Committee has dismissed an application to be restored to the Register of Veterinary Surgeons from a former Kent-based veterinary surgeon, Warwick Seymour-Hamilton.
Mr Seymour-Hamilton was originally removed from the Register in June 1994 for failing to maintain his equipment and facilities such that it evidenced a total disregard of basic hygiene and care for animals, thereby bringing the profession into disrepute.
The restoration hearing on Friday 18 March was Mr Seymour-Hamilton’s fourth application for restoration, with previous applications being submitted but refused in July 1995, June 2010 and January 2015. However, as the Committee made its decision on the merits of the case before it, those previous applications were not admitted as relevant to its decision.
Mr Seymour-Hamilton told the Committee that he currently works as a herbalist and naturopath for humans and wished to be restored to the Register so he could include animals in his research. He had completed a course in herbal and naturopathic medicine at the College of Naturopathic Medicine in Dublin in 2010, and told the Committee that he believed that being restored to the Register would lend credence to his endeavours to secure funding and other support. He stated that he did not intend to work again in a veterinary practice.
However, the Committee rejected his application on a number of grounds, including the impact on animal welfare should Mr Seymour-Hamilton be restored to the Register; the length of time he had been off the Register and the fact that he was therefore not up-to-date with contemporary veterinary practice and professional conduct; and that his efforts to keep up-to-date in terms of knowledge, skills and developments in practice were insufficient.
Judith Webb, chairing the Committee and speaking on its behalf, said: "The Committee is concerned about the length of time that has passed since he last practised and the paucity of the evidence he has provided to establish that, if permitted to return to practice, he would be able to attain the professional standards required of a modern veterinary practitioner, either as regards surgical capabilities/competence or as regards his knowledge of currently available veterinary medicines."
She added: "This Committee’s obligations and duties are to see that the interests of animal welfare are properly protected by ensuring that only those who are properly trained, knowledgeable and experienced are permitted to treat animals and that public confidence in the standards of the profession are maintained. The risks attendant on a restoration of this applicant to the Register are, in the judgement of this Committee, plain and obvious. Accordingly, this application is refused."
Ridgeway Research Ltd has a surplus supply of short-dated Target IgG kits on special offer.
The kits are to test for passive transfer to foals via colostrum. Each kit contains 20 tests and normally costs £74. They have been reduced to £20 to clear. The use by date is end February 2010.
If you are interested, please email jo@ridgewayresearch.co.uk, or ring 01594 530809 for further information.
The RCVS Trust has announced 34 grants totalling approximately £165,000, being made to veterinary surgeons, universities and higher education (HE) establishments, to fund high-quality research projects in the UK and overseas, and support veterinary education.
Harper Adams University College and Myerscough College will be the first veterinary nursing colleges to receive funding under the Spencer-Hill equipment grants programme; this was the first time that RCVS-approved HE veterinary nurse training providers were able to apply for this funding. Harper Adams will receive £2,350 to purchase a Humphrey ADE-circle system, and Myerscough, £1,395 for an 'Emily' canine positioning mannequin.
Severine Tasker MRCVS, from the University of Bristol, and Janet Patterson-Kane MRCVS, from the University of Glasgow each received Blue Sky Awards of £17,000. Severine will conduct research into constructing defined feline coronavirus strains for determination of the role of virus genetics in the development of feline infectious peritonitis. Janet Patterson-Kane's research will investigate whether a new therapy for treating wounds in humans can be translated for use in horses.
Janet said: "Limb wounds in horses are very common and are notorious for developing masses of exuberant scar tissue - proud flesh - and not healing properly. This can necessitate multiple operations. The findings of current research at University College London by our collaborator, Professor David Becker, suggest that in human patients a protein, connexin 43, is not downregulated at the edges of wounds that are difficult to heal. Use of therapy to reduce connexin 43 expression in human skin wounds in which healing has stalled has been remarkably successful in achieving wound closure. The aim of our research is to determine if connexin 43 plays a similar key role as a 'master switch' for wound healing in horses. I am extremely grateful to the RCVS Trust for their support."
Six veterinary undergraduates will also receive EMS vacation research scholarships of £700 each, which can be used to fund expenses relating to a research project undertaken in the UK or overseas as part of a UK veterinary school's extra-mural studies requirement.
Full details of the RCVS Trust grant awards may be found at www.rcvstrust.org.uk/awards
Researchers at the Royal Veterinary College have officially launched a new Feline Diabetic Remission Clinic in the Queen Mother Hospital for Animals in Hertfordshire, to investigate the optimum methods to achieve good control, and ultimately diabetic remission, in diabetic cats.
Led by Dr Stijn Niessen, the team at the new clinic will offer diabetic cats optimum management, while at the same time gathering information to enhance current scientific understanding of the best treatment for diabetic cats.
Feline diabetes mellitus is a costly, chronic disease which can significantly decrease the quality of life of both cat owners and their pets. However, a proportion of diabetic cats can achieve diabetic remission and no longer require insulin therapy, which is increasingly considered the ultimate goal in treating diabetic cats. According to the RVC, early evidence suggests that good, early blood glucose control increases remission rates in diabetic cats. However, there is little evidence about which treatment protocol offers the best blood glucose control and chance of remission.Stijn said: "Our mission is to investigate the best method of achieving good blood glucose control, and diabetic remission, in diabetic cats. The clinic also aims to identify predictors of diabetic remission, which will help veterinarians advise their clients on the chance of their cat achieving diabetic remission in the future."
He added: "Interestingly, most cats seem to suffer from a similar type of diabetes as most humans. We always suspected cats to be extremely wise, but isn't it interesting to know that they also might hold the answer to many questions we have about the human disease!"
The clinic is currently recruiting cats that have had diabetes for less than 4 months' duration for a clinical trial, examining the effect of new insulins on blood glucose control and remission rate.
Enrolled cats will qualify for full underlying disease assessment at the referral hospital, several re-examination appointments, 12 months of prescription diabetic food, and 6 months of insulin therapy - all at no cost to owners.
For more information on the trial or the work of the clinic, contact Feline Diabetic Remission Clinic: telephone: 01707 666 605 or email: fdrc@rvc.ac.uk
The free app is designed to help to track changes and improvements in a dog’s health during treatment.
The app uses questionnaires to monitor clinical signs and quality of life and includes reminders for when checkups with routine blood tests should be carried out, which Dechra says are recommended at 10 days, 4 weeks, 12 weeks and every 3 months thereafter.
The app also sends pet owners daily reminders to administer medication to their dog.
Sarah Musgrave, companion animal brand manager at Dechra, said: “Continuous and consistent monitoring is key to finding the right Vetoryl dose for a dog with Cushing’s and restoring its health.
"The new Cushing’s syndrome treatment and monitoring app is a useful tool to help owners quickly and easily record and track any medical and lifestyle changes in dogs being treated with Vetoryl, which can then be shared with their vet during check-ups.”
To download the app, search for 'Cushing's monitoring' on either Apple's App Store or the Google Play Store.
A survey carried out by Intervet/Schering-Plough Animal Health to launch Plerion, a chewable, flavoured wormer for dogs, has shown that most UK dog owners turn to their vet rather than a pet shop for advice on worming.
Over 83% of owners who took part in the survey said they follow their vet's advice on worming whilst fewer than 8% would follow the advice of their local pet shop. 63% choose to buy wormers from their vet against 35% buying wormers from a pet shop or online pharmacy.
Survey participants understood the importance of carrying out a regular worming programme with almost 80% stating that a dog should be wormed every three to four months. However, some owners cited forgetfulness as a reason for not worming their pet regularly and expressed a need for a reminder from their local vet practice.
Almost 85% of those who took part in the survey believed that not all wormers provide the same level of protection and almost 75% said that vet recommendation is the reason they purchase a specific brand of wormer. 94% of owners are aware that worms can affect people as well as dogs.
The survey revealed that 1 in 5 owners experienced difficulty in administering a complete dose due to their dog spitting out part or the entire tablet.
Intervet/Schering Plough says that Plerion should help reduce compliance issues; its innovative and tasty soft chew formulation meaning that most dogs will take it right out of the hand.
Sarah-Jane Minter, marketing manager at Intervet/Schering-Plough said: "When developing Plerion we knew it was essential to launch a product that made life easier for dog owners by being easy, and even fun, to administer as this would increase the likelihood of owners sticking to a regular worming programme. We are delighted by the feedback we are receiving from owners who report their once fussy dogs are taking the flavoured, chewable Plerion tablets as though they were treats."
Plerion is available in two tablet sizes that provide a combination of Pyrantel, Praziquantel and Oxantel which, the company says, gives effective treatment for the major endoparasites in a single dose including tapeworm Echinococcus multilocularis, as required by the Pets Travel Scheme (PETS).
For further information, please contact your local Intervet/Schering-Plough Veterinary Business Manager or phone the company's Veterinary Support Group on 01908 685685.
Norbrook Laboratories has launched NoroQuin, a nutritional glucosamine-based supplement which the company claims will help maintain healthy cartilage and joint fluids in cats, dogs and horses.
The NoroQuin range has six active ingredients including glucosamine, chondroitin sulphate, manganese sulphate, zinc sulphate, absorbic acid and N-Acetyl-D-Glucosamine which combine to maintain glycosaminoglycans (GAGs) levels in joints and, according to Norbrook, ease and reduce the onset of joint damage and cartilage degeneration.
Michelle Jones, Norbrook Brand Manager, said: "Our new NoroQuin range is an exciting new development to our joint-management range.
"NoroQuin offers more ingredients than the competition with 6 active ingredients working together to help improve mobility. The main ingredient, glucosamine stimulates natural repair and prevents cartilage degeneration and thinning while it is widely considered that glucosamine and chondroitin sulphate have anti-inflammatory properties, making Noroquin ideal for assisting with pain management. The addition of manganese sulphate helps stimulate natural cartilage repair."
NoroQuin is available in a range of meat flavoured tablet sizes that have been formulated to treat all dogs from growing puppies to the largest dogs. For cats, the range is available in a tablet form or as a powder which can be added to a cat's food.
NoroQuin for dogs and cats is available to order from wholesalers now.
Ceva Animal Health has launched Hepaticare, a new liver support supplement for cats and dogs.
The company says Hepaticare contains the same high quality ingredients as Hepatosyl, but is now enhanced with micro-encapsulated SAMe to enhance product stability and patient acceptance.
Hepaticare contains the antioxidants of S-adenosylmethionine (SAMe), vitamin E and silybin to help maintain liver function, and vitamin K to support the normal blood clotting process. Ceva says these ingredients help neutralise damaging free radicals produced by the liver during times of stress, while the SAMe has been micro-encapsulated to enhance stability, reduce any bitter aftertaste and increase patient acceptance.
Hepaticare capsules can be given whole or opened and sprinkled onto, or mixed with, food.
Rob McLintock, companion animal business unit manager at Ceva Animal Health, said: “Following a change in supplier we have taken the opportunity to launch a new liver support supplement, ensuring that the new and improved product, Hepaticare, is as effective and as easy to administer as possible.”
Hepaticare pack sizes and pricing will remain the same as for Ceva’s Hepatosyl. Until the end of September, Hepaticare will be available on a buy one get one free offer.
For further information, contact your local Ceva territory manager or phone 01494 781510.
The report says the greatest threat to farm animal welfare standards post-Brexit would come from UK farmers competing against cheap, imported food from countries that produce to lower standards than the UK. Therefore, the Government's wish for the UK to become a global leader in free trade is not necessarily compatible with its desire to maintain high animal welfare standards.
Noting the UK's overwhelming reliance on non-UK EU citizens to fill crucial official veterinary positions in the UK, the Committee called on the Government to ensure that the industry is able to retain or recruit qualified staff to fill these roles post-Brexit.
Responding to the report, BVA President Gudrun Ravetz said: "The report offers strong leadership and a clear message, emphasising the consumer and cross-sector consensus that current animal health and welfare standards must be at least maintained in Brexit negotiations. Prioritising these standards in trade negotiations could guarantee a unique selling point for the UK. As the report recommends, as consumers we must make sure we do not compromise quality for cost-savings in order to avoid a race to the bottom for welfare standards. We now need clarity from the Government on how underpinning processes and overarching principles, like Article 13 which ensures animal welfare requirements are fully considered in policy-setting, will be incorporated into domestic law.
"The report supports our view that animal welfare should be considered a public good and we reiterate our calls following the Secretary of State’s recent speech that a replacement CAP scheme should encompass animal welfare, animal health, disease surveillance, biodiversity and environmental stewardship to benefit not only UK producers, but consumers and wider society too.
"The EU Committee’s recognition of the vital role vets play in animal health, welfare and public health is extremely encouraging. Official Veterinarians (OVs) working in abattoirs protect and reassure UK consumers, certifying and supervising the import and export of animals and animal products to third countries. As I outlined in my evidence to the Committee, some estimates suggest 95% of OVs working in UK abattoirs graduated overseas, mostly in the EU. However, we are already hearing of fewer applicants for veterinary public health roles since the referendum.
"There are significant concerns about the potential impact of a post-Brexit veterinary workforce shortage on the UK's £100 billion agri-food sector, in terms of risking business and consumer confidence as well as the UK’s future export capability. A strong, sustainable veterinary workforce is absolutely vital to safeguarding animal health, welfare and public health post Brexit."
The research is being carried out by James Glass MRCVS (pictured), a PhD researcher working in the Suicide Behaviour Research Lab at the University of Glasgow, supervised by Professor Rory O'Connor - current president of the International Association for Suicide Prevention.
To take part, vets and student vets are being asked to complete a 15-25 minute survey, which must be done in one sitting.
Survey answers are strictly confidential.
Everyone is invited to participate, regardless of whether or not you have experienced suicidal thoughts, however James cautions that some of the questions may be upsetting for anyone currently experiencing suicidal feelings, and emphasises that participants are free to withdraw from the study at any point by closing the webpage, whereupon any answers already submitted with be discarded.
The study is open until 31st December 2024.
https://tinyurl.com/StudyTeamVet
The RCVS Officers will be heading to Somerset, home ground of President Bob Moore, on Thursday 22 May for RCVS Question Time.
The Shrubbery Hotel in Ilminster is the venue for the final Regional Question Time of Bob Moore’s Presidential year, where he looks forward to seeing lots of familiar faces for a lively debate.
Veterinary surgeons, veterinary nurses and others involved in the profession are all welcome to attend the meeting, which kicks off at 6:30pm with a relaxing drink, a bite to eat and a chance to catch up with colleagues, followed by Question Time at 7:15pm. The meeting will finish at approximately 10:00pm.
Bob Moore will be chairing the meeting and the panel will be made up of the Officer team and Veterinary Nurses Council Chairman Andrea Jeffery, who will be answering your questions and concerns regarding the veterinary profession.
Hot topics expected to be raised on the night include the RCVS Practice Standards Scheme, a new Veterinary Surgeons Act, RCVS modular certificate, 24-hour cover, the Professional Development Phase and the non-statutory Register for veterinary nurses.
To book your place contact Fiona Clark at the RCVS on 020 7202 0773 or f.clark@rcvs.org.uk before 9 May 2008, or download an invitation at http://www.rcvs.org.uk/ and post it to the address supplied. All veterinary surgeons and veterinary nurses living within reasonable travelling distance of the meeting venue will be sent a personal invitation.
If you are unable to attend the meeting, but have a question you would like to raise, please do write in.
Merial has launched Equioxx, a new pain management product which the company says is the first COX-2 specific NSAID for horses
Traditional NSAIDs act by blocking the action of both COX-1 and COX-2 enzymes at the same time. Although COX-2 produces prostaglandins associated with both inflammation and pain, COX-1 has a pivotal role in maintaining normal physiological function, so inhibiting this enzyme may have an increased risk of side effects e.g. gastric ulceration. Merial says Equioxx is the only NSAID that is highly COX-2 selective (up to 643 times more selective for COX-2 than COX-1), acting to reduce pain and inflammation but without affecting the COX-1 enzyme at therapeutic levels.
Equioxx contains the active ingredient firocoxib, and Merial says it is proven to be effective at reducing chronic lameness in horses. Appearing in blood plasma within 30 minutes of oral dosing, its pharmacokinetic profile allows once daily dosing. Field studies have confirmed that firocoxib is highly effective at controlling pain and improving function in horses with chronic osteoarthritis.
Equioxx is available as either a low dose injectable solution or a palatable oral paste.
For more information contact Merial Customer Services on 0870 6000 123
DairyCo has announced the launch of a new programme designed to tackle the challenge of lameness on dairy farms.
The Healthy Feet Programme has been developed to provide a structured approach to assist vets and foot trimmers to work more closely with their farmer clients, to reduce the incidence of lameness on a permanent basis.
DairyCo product manager, Kate Cross said: "We've developed the programme to build on the DairyCo Mobility Score by introducing a programme that dairy farmers can undertake working with their vet who is a trained 'mobility mentor', to identify problems, risk factors and suitable intervention strategies on the farm. An action plan is then agreed to prioritise management practices that have a permanent impact on incidence of lameness."
The programme draws on the findings from the Bristol Healthy Feet Project, the New Zealand Healthy Hooves programme, First Steps and Claw Signals. As well as the valuable experience gained from the DairyCo mastitis plan. It has been designed to combine the best features of all these programmes and aims to build on the successful DairyCo Mobility Score.
Vets are invited to enrol for a two day CPD course, which will enable them to introduce the Healthy Feet Programme to their farmer clients and provide on-going support, assisted by a range of resources provided by DairyCo.
The first course is scheduled for June 2011
For further details please contact Kate Cross on 02476 478686 or email healthyfeet@dairyco.ahdb.org.uk
A collaborative team of researchers from the Waltham Centre for Pet Nutrition has shown that adding moisture to a cat's diet leads to an increase in activity and may help slow down weight gain.
In a series of studies conducted in partnership with the University of Aberdeen, Waltham scientists found that cats fed a dry diet with added water were more physically active and gained less weight than those cats fed the dry diet alone. According to the Centre, this is the first time reduced energy density diets have been associated with an increase in physical activity levels in cats.
Waltham scientist and author of the study, Dr. Penelope Morris, said: "These findings advance our understanding of the factors that influence body weight in cats and provide a strong basis for further research.
"Obesity is a growing problem in the cat population, recent figures indicate that up to 50 per cent of cats are either overweight or obese. These findings could have important implications for developing tailored diets that meet cats' energy and nutritional needs."
The research is part of a wider programme of ongoing collaborative research into the effect of food and nutrition on body weight in both cats and dogs.
The research has been published in the June edition (Volume 95, Issue 3) of the Journal of Animal Physiology and Animal Nutrition and is available in print and online: http://onlinelibrary.wiley.com/doi/10.1111/j.1439-0396.2010.01107.x/abstract
The service will be headed by José C. Almansa Ruiz DVM (Hons) MSc (Vet) MRCVS.
José qualified from the Universidad Complutense de Madrid in 2008, before completing an honours degree in dentistry and maxillofacial surgery while working in an after-hours veterinary emergency hospital in Madrid.
In 2009, he relocated to South Africa where he undertook an internship in dentistry and maxillofacial surgery at the academic hospital of the faculty of veterinary science of the University of Pretoria. In 2011, he relocated to the UK and, in 2012, began the European Veterinary Dental College diploma.
In 2015, he returned to South Africa, working in referral hospitals, before being appointed as an extraordinary lecturer in veterinary dentistry and maxillofacial surgery at the Faculty of Veterinary Science of the University of Pretoria in January 2018.
This summer, José will sit the exams to become a European Specialist in Veterinary Dentistry.
Tim Richardson, managing director of both Southfields and Davies, said: “We look forward to welcoming José to the teams at both Southfields and Davies. He brings with him a wealth of experience and knowledge in his field and is a highly-respected clinician.
"The launch of dentistry and maxillofacial services at our multi-disciplinary referral centres is another exciting addition and we’re looking forward to accepting referrals from colleagues across the profession as we continue to lead the industry in the breadth of treatments that we can now offer.”
José said: “I’m delighted to be joining the teams at Southfields and Davies, and my plan is to establish and really grow a dentistry and maxillofacial surgery service over the coming 12 months.
“I would like to start offering reconstruction techniques for those patients undergoing mandibulectomies, while I have been hoping for some time now to begin using 3D printing as part of the planning for big surgeries.
“We will be offering a very complete and advanced veterinary dentistry service. From the maxillofacial surgery point of view, fracture repair procedures will see the introduction of non-invasive techniques for repair of maxillomandibular fractures.
“Craniofacial trauma cases will be worked up more in-depth together with anaesthesia, diagnostic imaging, ophthalmology, critical care and neurology, which will offer a truly multidisciplinary approach.”
For more information, visit www.southfields.co.uk or vetspecialists.co.uk.
Virbac has announced that it is to increase production of cat vaccines at its French plants to help practices in the UK manage a shortfall in supply.
The predicted shortfall follows warnings by other manufacturers of stock shortages of between three and six months.
Virbac, which makes the Feligen RCP, Leucogen and Leucofeligen cat vaccines, says it wants to reassure practices that it will do its utmost to ensure continuity of supply during this period and is urging them to order as usual and not stockpile product, which could exacerbate the problem.
Simon Boulton MRCVS, Product Manager for Virbac's vaccine range, said: "Our priority is to keep stock flowing to our existing customers. With this in mind, we've now ceased to supply wholesalers with our cat vaccines. Once wholesaler stocks have been depleted, we ask customers to contact us directly so that stock can be despatched to them from our own warehouse.
By taking this step, we can manage our own stocks effectively and, while we'll be putting our existing customers first, we also stand ready to help supply the rest of the veterinary sector during this period. As a primary manufacturer of vaccines, we're well placed to react quickly to stock shortages and expect to have significantly increased supply by November."
Practices wanting further information should contact their Virbac Territory Manager. Direct orders to the company should be made by calling Virbac on 01359 243243 and selecting Option Three (Direct Orders).
The Royal College has announced that a Legislative Reform Order (LRO) to reconstitute its disciplinary committees separately from its Council has been signed by Defra Minister David Heath, and will come into force on 6 April 2013.
The LRO will amend Part I of Schedule 2 of the Veterinary Surgeons Act 1966 (VSA) and require that the RCVS Preliminary Investigation and Disciplinary Committees are made up of veterinary surgeons and lay members who are not RCVS Council members, and who are appointed independently.
This will ensure that the same group of people is not responsible for setting the rules, investigating complaints and adjudication, and will bring lay people formally into the Preliminary Investigation Committee.
The LRO will also allow the RCVS to increase the pool of people available to investigate complaints and sit on disciplinary hearings, reducing the workload on the individual Committee members whose primary appointment is to RCVS Council.
The RCVS has been working on the LRO with Department of Environment, Food and Rural Affairs (Defra) officials since late 2010, and the Order was based on consultations undertaken by the RCVS and Defra.
According to the College, the Order was commended at every stage of Parliamentary scrutiny as an effective means to address the single biggest deficit of the VSA and to improve how the RCVS regulates the profession. During debate in Grand Committee of the House of Lords on 10 January, the RCVS received considerable praise for its strenuous efforts to modernise under the constraints of the present legislation, and the LRO received unanimous support.
Following the Order coming into force, the first external members will join the Disciplinary and Preliminary Investigation Committees from July 2013. After a two-year transition period, members of the RCVS Council will become ineligible for membership of these committees. Information about how to apply to join these committees will be available shortly.
President Jacqui Molyneux said: "I am delighted the LRO has been made and I am immensely thankful for the hard work of the Defra team and my colleagues in the College. The LRO is the single biggest reform to the regulation of veterinary surgeons since the 1966 Act, and it will bring the RCVS in line with regulatory best practice and improve the perception of the independence of the RCVS disciplinary processes."
The 15 minute video (see below) is hosted by Chris Dixon, veterinary ophthalmologist and director at Veterinary Vision Ophthalmic Referrals, who discusses things to consider when examining a patient with an ocular disorder. He offers practical advice on how to perform an ocular examination, including tips on how to use an ophthalmoscope effectively, examining the ocular structures including the front eye, distant direct examination, indirect examination and close direct examination.
Chris said: "This series of videos aims to help vets learn how to perform the fundamental techniques of ophthalmic examination, hopefully enabling them to spot potentially degenerative conditions earlier. The second video in particular delves into practical tips that vets can use within practice. The videos have been created in partnership with Bayer as part of their ongoing commitment to training, and aim to help ensure that chronic conditions, such as keratoconjunctivitis sicca (KCS), or dry eye, are diagnosed and treated early."
The veterinary practice waiting room display materials are designed to help practices educate dog owners on the signs and management of Dry Eye in the hope that the condition may be diagnosed and treated earlier and to emphasise the importance of ongoing treatment and management.
Hannah Watts, Group Product Manager at Bayer said: "It is important that dog owners with a predisposed breed are aware that their pet may be at risk of developing Dry Eye and are aware of the symptoms. Annual testing in at risk breeds for Dry Eye is recommended to help reach an early diagnosis and optimise the chances of a successful treatment outcome."
The Dry Eye practice display materials are available to order via the Bayer Vet Centre www.vetcentre.bayer.co.uk. Alternatively, ask your Bayer rep for more details.
fVtqNMj35c8
The two sets of guidance cover:
RCVS President Dr Mandisa Green said: “I would like to reassure my colleagues once again that we understand the extreme challenges and difficult decisions they are facing.
"The College has no interest in taking anyone to task for considered professional judgement, providing they act reasonably in the circumstances, can justify their actions and take reasonable notes.
"Sadly, we’re seeing the pandemic situation deteriorating again in the UK, but to varying degrees across the country. This presents a significant challenge in ensuring our guidance is clear and straightforward, while remaining relevant to as many people as possible.
"We sincerely hope this new guidance achieves that aim and supports veterinary professionals working to uphold animal health and welfare, while maintaining the safety of their teams and clients."
For more information, visit: https://www.rcvs.org.uk/setting-standards/advice-and-guidance/coronavirus-covid-19/
Elanco Companion Animal Health, maker of Comfortis, has launched a new campaign to raise awareness of the perennial problem of fleas, and the importance of regular treatment.
The campaign revolves around some new research which shows that while nearly half of dog owners1 allow their pets to swim at least once a month during the summer, over 45% of those questioned were unaware that if a dog is bathed or swims it may lose protection from spot-on flea treatments with only a sixth realising that the active ingredients in some spot-on insecticides can harm aquatic organisms2.
Gavin and Stacey actress Joanna Page, and RSPCA veterinary surgeon David Grant (pictured right) are being wheeled out to talk about the new research, both on the radio and on web TV.
In addition, Elanco says that a range of Comfortis support materials are available to help educate pet owners about fleas and the healthcare issues associated with fleas and encourage enquiries about flea control solutions.
For further information please contact your local Elanco Companion Animal Health key account manager or email elancoah.uk@lilly.com.
References